Swelum Ayman Abdel-Aziz, Alowaimer Abdullah Nasser
Department of Animal Production, College of Food and Agriculture Sciences, King Saud University, Riyadh, Saudi Arabia; Department of Theriogenology, Faculty of Veterinary Medicine, Zagazig University, Sharkia, Egypt.
Department of Animal Production, College of Food and Agriculture Sciences, King Saud University, Riyadh, Saudi Arabia.
Theriogenology. 2015 Dec;84(9):1542-8. doi: 10.1016/j.theriogenology.2015.08.003. Epub 2015 Aug 10.
The present study aimed to evaluate the efficacy of controlled internal drug release (CIDR) to synchronize the follicular wave in dromedary camels (Camelus dromedarius) during the breeding season through ovarian monitoring, evaluating sexual receptivity, and measuring progesterone (P4) and estradiol (E2) levels during and after CIDR treatment. Sixteen camels received a new CIDR containing 1.9 g of P4 for 14 days. Ultrasound ovarian monitoring was performed on the day of insertion and every 3 days until the CIDR was withdrawn. Ultrasound examinations were continued day in day out after the CIDR was withdrawn for 10 days. According to the ultrasound examinations, the percentages of camels in the breeding (follicles: 12-18 mm) and nonbreeding phases were calculated. Blood samples were collected day after day during the experimental period (24 days) from the day that the CIDR was inserted. The serum P4 and E2 concentrations were analyzed using ELISA kits. The sexual receptivity of the camels was tested daily during the course of the experiment. The results revealed that 2 and 4 days after the CIDR was withdrawn, the percentage of camels in the breeding phase (68.75% and 75.00%, respectively) was significantly (P < 0.05) higher than that in the nonbreeding phase (31.25% and 25.00%, respectively). The percentage of camels that were abstinent during CIDR treatment was significantly (P < 0.05) higher than that observed for those who were incompletely receptive or completely receptive. The P4 levels increased significantly (P < 0.05) 2 days after CIDR insertion (1.73 ng/mL) and reached maximum values (2.94 ng/mL) at Day 12. Significant (P < 0.05) decreases in the P4 levels were observed 2 to 4 days after CIDR withdrawal (1.01 and 0.80 ng/mL, respectively). The P4 levels reached minimum values (0.18-0.22 ng/mL) at Day 20 through the end of the experiment. The E2 levels differed insignificantly during and after CIDR treatment in dromedary camels. In conclusion, the treatment of dromedary camels with CIDR produced a uniform increase in serum concentrations of P4 that could completely prevent sexual receptivity but could not suppress the follicular wave. After CIDR withdrawal, the P4 levels fell and induced the emergence of a new follicular wave, and most of the camels were in the breeding (ovulatory) phase 2 to 4 days after withdrawal. Therefore, CIDR can be used to synchronize the follicular wave in dromedary camels.
本研究旨在通过卵巢监测、评估性接受能力以及测量孕酮(P4)和雌二醇(E2)水平,来评价在繁殖季节使用控制内部药物释放(CIDR)同步单峰骆驼(Camelus dromedarius)卵泡波的效果,监测时间为CIDR治疗期间及之后。16头骆驼接受了含1.9克P4的新型CIDR,持续14天。在插入CIDR当天及之后每3天进行一次超声卵巢监测,直至取出CIDR。取出CIDR后持续10天每日进行超声检查。根据超声检查结果,计算处于繁殖期(卵泡:12 - 18毫米)和非繁殖期的骆驼百分比。在实验期间(24天),从插入CIDR当天开始每日采集血样。使用酶联免疫吸附测定(ELISA)试剂盒分析血清P4和E2浓度。在实验过程中每日测试骆驼的性接受能力。结果显示,取出CIDR后2天和4天,处于繁殖期的骆驼百分比(分别为68.75%和75.00%)显著高于非繁殖期(分别为31.25%和25.00%)(P < 0.05)。在CIDR治疗期间禁欲的骆驼百分比显著高于不完全接受或完全接受的骆驼(P < 0.05)。插入CIDR后2天P4水平显著升高(P < 0.05)(1.73纳克/毫升),并在第12天达到最大值(2.94纳克/毫升)。取出CIDR后2至4天,P4水平显著下降(P < 0.05)(分别为1.01和0.80纳克/毫升)。在第20天至实验结束时,P4水平达到最小值(0.18 - 0.22纳克/毫升)。在单峰骆驼中,CIDR治疗期间及之后E2水平无显著差异。总之,用CIDR治疗单峰骆驼可使血清P4浓度均匀升高,能完全抑制性接受能力,但不能抑制卵泡波。取出CIDR后,P4水平下降并诱导新的卵泡波出现,大多数骆驼在取出后2至4天处于繁殖期(排卵)。因此,CIDR可用于同步单峰骆驼的卵泡波。